Rameda
Rameda, officially known as Rameda Pharmaceuticals, is a prominent player in the pharmaceutical industry, headquartered in Egypt (EG). Established in 1994, the company has made significant strides in the development and manufacturing of a diverse range of pharmaceutical products, including prescription medications, over-the-counter drugs, and dietary supplements. With a strong operational presence across the Middle East and North Africa, Rameda is recognised for its commitment to quality and innovation. The company’s core offerings include unique formulations that cater to various therapeutic areas, setting them apart in a competitive market. Rameda has achieved notable milestones, including regulatory approvals and partnerships that enhance its market position, solidifying its reputation as a trusted name in healthcare.
DitchCarbon Score
How does Rameda's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Rameda's score of 22 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Rameda's reported carbon emissions
Rameda, headquartered in Egypt (EG), currently does not have publicly available carbon emissions data for recent years. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not provided. Despite the absence of emissions data, Rameda is committed to addressing climate change through various initiatives. However, no specific reduction targets or climate pledges have been disclosed. This lack of detailed information highlights the need for greater transparency in their environmental strategies. As the pharmaceutical industry increasingly focuses on sustainability, Rameda's future commitments and actions will be crucial in aligning with global climate goals and reducing their environmental impact.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Rameda is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
